Učitavanje...
A Public Health Approach to the Prevention of Inhibitors in Hemophilia
The development of an antibody in people with hemophilia to products used in the treatment and prevention of bleeding, also referred to as an inhibitor, is the most serious complication of hemophilia care today. CDC, together with healthcare providers, consumer organizations, hemophilia organization...
Spremljeno u:
| Izdano u: | Am J Prev Med |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4469363/ https://ncbi.nlm.nih.gov/pubmed/25245801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2014.07.007 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|